HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Stanford interviews: GLP-1 users describe quieter 'food noise', side effects and stigma

Louis Nervegna · Jul 05, 2026 · ♥ 6 reactions · 0 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)
AI summary & key facts

A JAMA Network Open qualitative study of 30 US adults found reduced food noise, renewed agency, side effects, stigma and access barriers.

#glp1HD

Research cited

"My whole world revolved around food."

In a new JAMA Network Open study from the Stanford Center for Digital Health, researchers interviewed 30 adults across the U.S. about what it is actually like to take GLP-1 medications.

Participants described reduced "food noise," renewed agency around eating, side effects, stigma and barriers to access.

For many, the story was not only about weight loss. It was about what life felt like when food was no longer in charge.

Read more:

Department of MedicineQuieting the Food Noise: Inside the Real Experience of GLP-1 MedicationsThrough patient interviews, Stanford researchers reveal the real experience of GLP-1 medications, including quieted cravings, side effects, stigma, and barriers to access.medicine.stanford.edu
#stanford#weightloss#jama
← newer: Vigorous exercise can cut visceral fat without calorie deficolder: Low blood vitamin C linked to brain changes, likely a proxy →